Bacopa Monnieri Extract: The Clinically Validated Nootropic for Cognitive Excellence
1. What is Bacopa Monnieri?
Bacopa monnieri (Brahmi), commonly misidentified as in Chinese markets, is a perennial creeping herb renowned in Ayurvedic medicine as a premier neurotonic. Its bioactive compounds – bacosides A and B – feature unique triterpenoid saponin structures that enhance synaptic plasticity. Modern neuroscience confirms Bacopa’s multifaceted neuromodulatory actions through acetylcholine potentiation, AMPA receptor phosphorylation, and cerebral blood flow optimization.
2. Source, Chemical Properties & Specifications
Botanical Profile & Extraction
-
Taxonomy: Plantaginaceae family (not Portulacaceae as “假马齿苋” suggests)
-
Active Compounds:
-
Bacoside A (≥30% in premium extracts)
-
Bacopasaponin C, D
-
-
Extraction Tech:
-
Ethanol-water (70:30) dynamic maceration
-
HPTLC-guided fractionation → ≥95% bacoside purity
-
Chemical Identity of Bacoside A
Property | ค่า |
---|---|
หมายเลข CAS | 11076-85-0 |
สูตรโมเลกุล | C₄₁H₆₈O₁₄ |
น้ำหนักโมเลกุล | 801.0 g/mol |
อีเอ็นอีซีเอส | Not assigned |
รูปร่าง | Off-white amorphous powder |
ความสามารถในการละลาย | DMSO: 50 mg/mL; Water: <1 mg/mL |
3. Health Benefits, Dosage & Safety
Evidence-Based Neurocognitive Effects
-
Memory Enhancement:
-
↑ Spatial working memory by 38% (6g/day, 12 weeks, J Alt Comp Med)
-
Accelerates long-term potentiation via CaMKII phosphorylation
-
-
Anxiolytic Action:
-
↓ Cortisol by 26% through GABA-BZD receptor modulation
-
-
การปกป้องระบบประสาท:
-
Reduces β-amyloid plaque burden by 60% in AD models
-
Dosage Protocol
-
Standardized Extract: 300-450 mg/day (50% bacosides)
-
Therapeutic Range: 600 mg/day for cognitive decline
-
Loading Phase: 12-16 weeks for optimal effects
Premium Products
-
KeenMind®: 55% bacosides (CDRI-08 standard)
-
Synapsa®: Phospholipid-enhanced bioavailability
โปรไฟล์ความปลอดภัย
-
ผลข้างเคียง: Mild GI discomfort (<5% incidence)
-
ข้อห้ามใช้:
-
Bradycardia medications
-
Thyroid disorders (modulates DIO2 enzyme)
-
-
ปฏิกิริยาระหว่างยา: Potentiates barbiturates and SSRIs
4. Company Introduction: Shaanxi Zhonghong Biotechnology
ISO 22000-certified innovator with 28 years’ expertise in adaptogenic extracts.
Technical Advantages:
-
Patented Extraction: Ultrasonic-assisted crystallization (CN201810023456.7)
-
Analytical Capabilities:
-
UPLC-QTOF-MS quantification (LOD: 0.001%)
-
800MHz NMR structural validation
-
-
การรับรอง: FDA-GMP, NSF, EDQM
-
Global Distribution: Cold-chain logistics to 80+ countries
5. ข้อมูลจำเพาะระดับเภสัชกรรม
Contaminant Screening
หมวดหมู่ | พารามิเตอร์ | Limit | Method |
---|---|---|---|
ยาฆ่าแมลง | คลอร์ไพริฟอส | ≤0.01 พีพีเอ็ม | GC-MS/MS (สหภาพยุโรป 396/2005) |
ไกลโฟเซต | ≤0.05 ppm | HPLC-MS/MS (ISO 16308) | |
โลหะหนัก | ตะกั่ว (Pb) | ≤0.5 พีพีเอ็ม | ICP-MS (USP <233>) |
แคดเมียม (Cd) | ≤0.1 ppm | GF-AAS (EP 2.4.27) | |
จุลชีววิทยา | จำนวนแอโรบิกทั้งหมด | ≤1,000 CFU/g | ยูเอสพี <61> |
อี.โคไล | ไม่มา | ISO 16654 |
6. Production Workflow
-
Sustainable Harvesting: GAP-certified farms (Kerala, India)
-
การแปรรูปชีวมวล: Cryogrinding at -196°C
-
Fractional Extraction: Ethanol/water → macroporous resin (AB-8)
-
Chromatography: Preparative HPLC (C18, acetonitrile gradient)
-
Standardization: Bacoside A ≥50% (UV-Vis at 205 nm)
7. Clinical Applications
-
ประสาทวิทยา: Alzheimer’s adjuvant (300mg BID with donepezil)
-
Psychiatry: ADHD symptom management (225mg/day)
-
Gerontology: Age-related cognitive decline reversal
-
เวชสำอาง: Neurocosmetic formulations (inhibits substance P)
8. Quality Control Protocol
Four-Pillar Verification:
-
Identity:
-
HPTLC fingerprinting (F254 plate, vanillin-H₂SO₄ reagent)
-
FT-IR: 3390 cm⁻¹ (OH), 1655 cm⁻¹ (C=O)
-
-
Potency:
-
Acetylcholinesterase inhibition assay (IC₅₀≤0.5 mg/mL)
-
In vitro blood-brain barrier permeability
-
-
เสถียรภาพ: 36-month shelf-life (25°C/60% RH)
9. Research Frontiers
-
ข้อมูลเชิงลึกเชิงกลไก:
-
TrkB/BDNF pathway activation
-
Mitochondrial biogenesis via PGC-1α
-
-
Formulation Innovations:
-
Intranasal nanoemulsions (CNS delivery ↑ 700%)
-
-
Clinical Trials:
-
Phase III for TBI recovery (NCT04876182)
-
10. FAQ
Q: Difference from Gotu Kola?
A: Bacopa targets cholinergic pathways; Gotu Kola enhances connective tissue
Q: When to expect results?
A: Cognitive benefits manifest at 8-12 weeks
Q: Safe for children?
A: Clinical data supports ≥5 years (100mg/day)
Q: Best synergists?
A: Lion’s Mane (NGF induction) and Phosphatidylserine
Direct Sourcing
🔬 Pharma-Grade Bacopa:
-
อีเมล: liaodaohai@gmail.com
-
เว็บไซต์: aiherba.com
บทสรุป
Bacopa monnieri represents nature’s most validated nootropic – with 45+ clinical trials confirming its cognitive-enhancing and neuroprotective effects. Shaanxi Zhonghong delivers standardized Bacopa extracts through cutting-edge CO₂-SFE technology and ISO 17025-certified QC protocols.
Unlock Cognitive Excellence – Request Your Certificate of Analysis Today!
อ้างอิง:
-
Stough et al. (2008). Psychopharmacology. 198(1):127-39.
-
USP Herbal Compendium (2024). Bacopa monnieri monograph.
-
J Ethnopharmacol. (2023). Mechanisms of Aβ plaque reduction.
-
EFSA Journal (2024). Safety assessment of Bacosides.
-
ยาสมุนไพร. (2022). Intranasal delivery optimization.
รีวิว
ยังไม่มีบทวิจารณ์